Skip to main content
TipRanks
Go Ultimate75% OFF
Vivatides Therapeutics logo

Vivatides Therapeutics: Valuation, Funding & Investors

110 E 25th St 412 New York, NY 10010, UShttps://www.vi.co/Therapeutics

Vivatides Therapeutics is a global biotechnology company developing extrahepatic RNA-targeting therapeutics. It focuses on advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies, building an extrahepatic delivery platform and progressing multiple pipeline programs toward clinical development.

Leadership & Board

Current Number of Employees
5
Current LinkedIn Followers
2,556

Latest Estimated Valuation

Total Amount Raised
$54M
Total Funding Rounds
1
Latest Funding Amount
$54M
Latest Funding Round
Series A

Employee Trend

Vivatides Therapeutics had 5 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

5Latest Employee Count
0(0.00%)Week-Over-Week Change
02468Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

Vivatides Therapeutics had 2,556 followers as of November 16, 2026. The number of followers increased by 19 (0.75%) week-over-week.

2,556Latest Followers Count
19(0.75%)Week-Over-Week Change
01,0002,0003,0004,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Apr 10, 2026Series A$54.00M―

Investors

Investor NameFunding Round
Qiming Venture PartnersSeries A
Highlight CapitalSeries A
TF CapitalSeries A
Apricot CapitalSeries A

Similar Companies

A snapshot of private companies similar to Vivatides Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis